Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)

  • Read more about Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)

BLESSED: Expanded Access for DNG64 for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

  • Read more about BLESSED: Expanded Access for DNG64 for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of Breast

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

  • Read more about Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

  • Read more about Expanded Access Use of L-MTP-PE for the Treatment of Osteosarcoma

Domperidone Expanded Access Treatment Program

  • Read more about Domperidone Expanded Access Treatment Program

131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

  • Read more about 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young Adults

Treatment (Compassionate) Use of Device - PK Papyrus

  • Read more about Treatment (Compassionate) Use of Device - PK Papyrus

Expanded Access [11C] Methionine PET Imaging

  • Read more about Expanded Access [11C] Methionine PET Imaging

Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

  • Read more about Expanded Access Multi-Patient Experimental Treatment Involving Allogeneic Human Mesenchymal Stem Cells (hMSCs) in Subjects With Acute Ischemic Stroke (EXPAND)

TrueBinding Inc.

By jpalfreyman on Thu, 06/15/2023 - 17:02
  • Read more about TrueBinding Inc.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 152
  • Page 153
  • Page 154
  • Page 155
  • Current page 156
  • Page 157
  • Page 158
  • Page 159
  • Page 160
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA